Science News - March 3, 2026
Bacterial pathogens build antibiotic-resistant “bunkers”
Researchers at the University of Turku have discovered and characterised at the atomic level a mechanism that enables bacterial pathogens – including hospital bacteria Acinetobacter baumannii and Pseudomonas aeruginosa – to assemble antibiotic-resistant three-dimensional (3D) biofilms.
Science News - February 10, 2026
Nordic study maps KRAS and NRAS in metastatic colorectal cancer
Data from Finnish and Swedish cohorts link specific RAS mutation subtypes to distinct treatment outcomes, strengthening the evidence base for biomarker‑guided therapy.
Science News - February 9, 2026
Nordic registers reveal COVID‑19’s impact on cancer survival
A 2026 population‑based cohort study covering Denmark, Finland, Iceland, Norway and Sweden analysed 1‑year relative survival and excess mortality in cancer patients diagnosed during March–December 2020 versus expectations from 2011–2019.
Science News - February 4, 2026
New blood test signals early Parkinson’s
A Swedish–Norwegian research team has identified blood-based biomarkers that could flag Parkinson’s disease up to two decades before classic motor symptoms appear.
Science News - February 4, 2026
New boron compounds could lead to easier drug development
Researchers at the University of Gothenburg have developed a new class of boron–fluorine compounds that could make late‑stage optimisation of drugs and imaging agents both simpler and more sustainable. The work, published in Angewandte Chemie, introduces stable “BF₂‑boracycles” that can be made metal‑free, at scale, and without time‑consuming purification – yet remain highly reactive in […]
Science News - February 3, 2026
Google DeepMind’s new AI reads DNA’s ‘dark genome’
Google DeepMind has introduced AlphaGenome, a large deep learning model that predicts how changes in noncoding DNA affect gene regulation, aiming to unlock the “dark genome” for disease research and drug discovery (Agarwal et al., Nature, 2026).